PhD Maja Čemažar

PhD Maja Čemažar
no.: 14575 source: ARIS

researcher – active in research organisation
(01) 587 95 44
  mcemazarat signonko-i.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • French
  • Reading: Functional
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
3.01.00  Medical sciences  Microbiology and immunology   
Keywords
Experimental oncology, electroporotion, chemotherapy, radiobiology, electrochemotherapy
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
2,499.02
A''
121.25
A'
1,094.36
A1/2
1,568.55
CI10
7,023
CImax
464
h10
42
A1
6.86
A3
5
Data for the last 5 years (citations for the last 10 years) on April 16, 2026; Data for score A3 calculation refer to period 2020-2024 (2020, 2021, 2022, 2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 367  11,691  8,320  22.67 
Scopus 380  13,900  10,116  26.62 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Ajda Medved   Bologna doctoral studies    55824 
2 PhD Barbara Lisec   Bologna doctoral studies  10/1/2016 - 1/13/2022  39122 
3 PhD Katarina Žnidar   Bologna doctoral studies  11/1/2014 - 10/18/2019  37534 
4 PhD Urša Lampreht Tratar   Bologna doctoral studies  10/1/2013 - 8/21/2018  36367 
5 PhD Andreja Brožič   Bologna doctoral studies  12/1/2012 - 7/13/2016  35354 
6 PhD Nataša Tešić   Bologna doctoral studies  11/1/2011 - 5/4/2015  34477 
7 PhD Boštjan Markelc   Bologna doctoral studies  10/1/2009 - 3/31/2013  32175 
8 PhD Vesna Todorović   Uniform doctoral studies  10/1/2007 - 3/31/2011  29469 
9 PhD Gregor Tevž   Uniform doctoral studies  11/1/2005 - 4/30/2009  26164 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Biotechnical Faculty 1992 
Master's degree  M. Sc.     SI University of Ljubljana, Faculty of Medicine 1996 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 1998 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (80%, RD:80%)  Institute of Oncology Ljubljana  Department of research  11/1/1992  Research counsellor  Researcher   
Full time employment (30%, RD:15%)  Universita del Litorale, Facolta di Scienze della Salute  Raziskovalna skupina UP FVZ (Slovene)  9/19/2005  Professor  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head
1. L3-70150  Triad of Precision: A Synergistic 3dCAR-MSC Platform Targeting Melanoma via Immune Activation, TRAIL-induced Apoptosis, and PD-L1 Identification/Blockade   3/1/2026 - 2/28/2029  PhD Urban Švajger   2,566 
2. J3-60068  Circulating tumor cell translational research platform.   1/1/2025 - 12/31/2027  PhD Tanja Jesenko   3,102 
3. J1-60017  Perfusion, Edema, and Necrosis Evaluation using OCT for Tumor Outcome Measures   1/1/2025 - 12/31/2027  PhD Jošt Stergar   2,900 
4. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   10/1/2023 - 9/30/2026  PhD Katarina Žnidar   2,526 
5. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   10/1/2023 - 9/30/2026  PhD Nina Kostevšek   4,470 
6. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   10/1/2023 - 9/30/2026  PhD Maja Čemažar   3,193 
7. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   10/1/2023 - 9/30/2026  PhD Katja Uršič Valentinuzzi   3,567 
8. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   10/1/2023 - 9/30/2026  PhD Matej Reberšek   3,903 
9. J7-50128  Trace metals disorder as biomarker in biliary tract cancers   10/1/2023 - 9/30/2026  PhD Janez Ščančar   4,137 
10. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,978 
11. J7-4540  Socio-economic consequences of cancer from the perspective of the individual and society including the impact of COVID-19 pandemic   10/1/2022 - 6/30/2026  PhD Ivica Ratoša   5,790 
12. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   10/1/2022 - 9/30/2025  PhD Igor Muševič   6,170 
13. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   10/1/2022 - 9/30/2025  PhD Matej Sova   4,450 
14. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   10/1/2022 - 9/30/2025  PhD Metka Novak   2,132 
15. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,624 
16. BI-AT/23-24-004  The role of necroptosis in acute myeloid leukemia   1/1/2023 - 12/31/2024  PhD Maja Čemažar   1,632 
17. J3-3084  Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy   10/1/2021 - 12/31/2024  PhD Anže Smole   2,995 
18. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   9/1/2020 - 8/31/2023  PhD Maja Čemažar   3,578 
19. J4-2546  Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours   9/1/2020 - 8/31/2023  PhD Nataša Tozon Mask   4,041 
20. J3-2529  Role of endothelium in tumor response to radiotherapy   9/1/2020 - 8/31/2023  PhD Boštjan Markelc   3,914 
21. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   9/1/2020 - 8/31/2023  PhD Mateja Erdani Kreft   5,842 
22. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   7/1/2018 - 6/30/2021  PhD Gregor Serša   4,027 
23. N3-0059  Plasma-assisted wound treatment and topical introduction of molecules   1/1/2017 - 12/31/2020  PhD Uroš Cvelbar   3,459 
24. J4-8227  Preprečevanje rezistence tumorskih celic na antiproteazno terapijo z inhibitorji katepsina X. (Slovene)   5/1/2017 - 4/30/2020  PhD Janko Kos   5,269 
25. J3-8202  Spremljanje imunskega odziva v realnem času po in situ vakcinaciji z elektrokemoterapijo in pridruženo gensko terapijo z interlevkinom-12 (Slovene)   5/1/2017 - 4/30/2020  PhD Maja Čemažar   3,979 
26. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   3/1/2016 - 2/28/2019  PhD Igor Emri   4,836 
27. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   1/1/2016 - 12/31/2018  PhD Primož Strojan   4,733 
28. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments   1/1/2016 - 12/31/2018  PhD Mateja Erdani Kreft   7,874 
29. J1-6730  Razvoj novih celičnih linij človeških jeter za raziskave genotoksičnosti in karcinogenosti: novo upanje za človekovo zdravje in zaščito laboratorijskih živali (Slovene)   11/1/2014 - 10/31/2017  PhD Metka Filipič   4,594 
30. J3-6793  Novi pristopi radiosenzibilizacije tumorjev z gensko terapijo (Slovene)   7/1/2014 - 6/30/2017  PhD Gregor Serša   5,714 
31. J1-6744  Razvoj polimerov z molekularnimi odtisi in njihova uporaba na področju okoljske in bio-analitike (Slovene)   7/1/2014 - 6/30/2017  PhD Tina Kosjek   5,473 
32. J3-6796  Translacijska onkologija: razvoj in validacija imunsko genske terapije z interleukinom-12 v kombinaciji s kirurgijo pri oralnih in kožnih tumorjih psov (Slovene)   7/1/2014 - 6/30/2017  PhD Maja Čemažar   5,442 
33. J1-6734  Zaščita lahkih zlitin na osnovi aluminija kot materialov prihodnosti za transportno industrijo (Slovene)   7/1/2014 - 6/30/2017  PhD Ingrid Milošev   4,059 
34. J3-5505  Elektrokemoterapija globoko ležečih tumorjev (Slovene)   8/1/2013 - 7/31/2016  PhD Gregor Serša   4,740 
35. J4-5529  Nitroksolin in njegovi derivati kot nova protitumorska zdravila (Slovene)   8/1/2013 - 7/31/2016  PhD Janko Kos   6,798 
36. J3-4211  Antiangiogena genska terapija raka: tarčno zdravljenje z uporabo elektroporacije in magnetnih nanodelcev kot dostavnih sistemov (Slovene)   7/1/2011 - 6/30/2014  PhD Gregor Serša   7,136 
37. J1-4044  Apoptotično delovanje alkilpiridinijevih spojin na celice pljučnega adenokarcinoma (Slovene)   7/1/2011 - 6/30/2014  PhD Tom Turk   6,914 
38. J3-4259  Priprava in validacija terapevtskih plazmidov brez selekcijskega gena za antibiotično rezistenco za gensko terapijo raka z inducibilnimi in tkivno specifičnimi promotorji (Slovene)   7/1/2011 - 6/30/2014  PhD Maja Čemažar   6,568 
39. L2-4105  Razvoj programa za numerično modeliranje elektroporacije in vivo ter njegova validacija? in silico elektroporacija (Slovene)   7/1/2011 - 6/30/2014  PhD Damijan Miklavčič   5,379 
40. J1-4131  Sinteza, karakterizacija in uporaba novih rutenijevih spojin v elektrokemoterapiji tumorjev (Slovene)   7/1/2011 - 6/30/2014  PhD Iztok Turel   6,654 
41. J2-3639  Novi lipidni modelni sistemi za določitev mehanizmov elektroporacije (Slovene)   5/1/2010 - 4/30/2013  PhD Damijan Miklavčič   5,758 
42. J3-2277  Kombinacija elektrogenske imunske terapije z interlevkinom-12 in obsevanjem za zdravljenje eksperimentalnih tumorjev (Slovene)   5/1/2009 - 4/30/2012  PhD Maja Čemažar   3,089 
43. J3-2218  Ugotavljanje infekcije protez pri zamenjavi umetnih sklepov (Slovene)   5/1/2009 - 4/30/2012  PhD Andrej Cör   3,224 
44. J3-0485  Antiangiogenic siRNA for the treatment of advanced malignant melanoma   2/1/2008 - 1/30/2011  PhD Maja Čemažar   2,859 
45. J3-9580  Development of cell biosensor systems for determination of effects of ionizing radiation and chemical carcinogens   1/1/2007 - 12/31/2009  PhD Gregor Serša   2,771 
46. J7-9743  The impact of health care on the quality of life of elderly people: The influence of incontinence and impaired mobility on functionary of elderly people   1/1/2007 - 12/31/2009  PhD Maja Čemažar   3,261 
47. M1-0151  Molekularna detekcija posledic uporabe in delovanja biološkega orožja in toksinov z dolgodobnim delovanjem (Slovene)   6/1/2006 - 11/30/2008  PhD Metka Filipič   5,714 
48. J3-7044  Treatment of malignant tumours with electrogene therapy   9/1/2005 - 8/31/2008  PhD Maja Čemažar   3,634 
49. J3-6260  Vpliv infuzij nizkih odmerkov citostatikov na tumorske celice in pretok krvi v tumorjih (Slovene)   2/1/2004 - 1/30/2007  PhD Marija Auersperg   4,854 
50. L3-5012  MOLEKULAR GENETIC PREDISPOSITION FOR DEVELOPMENT OF SOME CANCERS   1/1/2003 - 12/31/2005  PhD Metka Ravnik-Glavač   5,038 
51. J3-4207  Ocena učinkovitosti presejanja za raka materničnega vratu v Sloveniji; študija primerov s kontrolami (Slovene)   7/1/2002 - 6/30/2005  PhD Maja Primic-Žakelj   3,389 
52. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   7/1/2002 - 6/30/2005  PhD Maja Čemažar   5,217 
53. J3-3489  New biomedical applications of electroporation   7/1/2001 - 6/30/2004  PhD Gregor Serša   4,403 
54. J3-2049  Uporaba elektroporacij v genski terapiji (Slovene)   1/1/2000 - 6/30/2002  PhD Maja Čemažar   4,472 
55. J3-7843  Elektrokemoterapija - nov pristop k zdravljenju raka (Slovene)   1/1/1996 - 6/30/2001  PhD Gregor Serša   4,444 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2022 - 12/31/2027 PhD Gregor Serša   4,636 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2015 - 12/31/2021 PhD Gregor Serša   3,707 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2009 - 12/31/2014 PhD Gregor Serša   4,457 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   7/1/2004 - 12/31/2008 PhD Gregor Serša   3,392 
International projects
no. Code Title Period Head
1. COST-TD1104  COST - European Network for Development of Electroporation-based technologies and treatments EP4Bio2Med   4/10/2012 - 4/9/2016 PhD Damijan Miklavčič    
2. INTERREG-TRANS2CARE    4/1/2011 - 9/30/2014 PhD Maja Čemažar    
Confirmation required
Views history
Favourite